BioMark’s Market Update Report
Vancouver, British Columbia – (February 4th, 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to provide a market update report with key activities undertaken by BioMark’s team during January 2020. “BioMark is not aware of any negative news that has impacted its share price recently. We continue to execute […]